Evidence map›Paper›PMID 37064879›Full record

ArticleTheranostics2023

Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy.

Ching-Hsin Huang, Edwin Chang, Li Zheng, Joe Gerald Jesu Raj, Wei Wu, Laura J Pisani, Heike E Daldrup-Link

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ching-Hsin HuangDepartment of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, CA, U.S.A.
Edwin ChangDepartment of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, CA, U.S.A.
Li ZhengSarafan Chemistry, Engineering & Medicine for Human Health (Chem-H), Stanford University, Stanford, CA, U.S.A.
Joe Gerald Jesu RajDepartment of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, CA, U.S.A.
Wei WuDepartment of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, CA, U.S.A.
Laura J PisaniDepartment of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, CA, U.S.A.
Heike E Daldrup-LinkDepartment of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, CA, U.S.A.
Center for Innovation · US

Funding

Theranostics for Pediatric Brain CancerR01HD103638 · NICHD · STANFORD UNIVERSITY · PI DALDRUP-LINK, HEIKE ELIZABETH · 2021 to 2025
$3.3M
NICHD NIH HHS R01 HD103638
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlioblastomaNanoparticlesAnimalsCell Line, TumorEndopeptidasesFerrosoferric OxideIronMagnetic Resonance ImagingMiceMice, NudePeptide HydrolasesPrecision MedicineEndopeptidasesFerrosoferric OxideIronPeptide HydrolasesglioblastomaMMAEMRInanoparticlestheranostic

Identifiers

PMID37064879
PMCPMC10091873
OpenAlexW4364321413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.